Oppenheimer Asset Management Inc. Sells 858 Shares of Avantor, Inc. (NYSE:AVTR)

Oppenheimer Asset Management Inc. lowered its holdings in Avantor, Inc. (NYSE:AVTR) by 0.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,830 shares of the company’s stock after selling 858 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Avantor were worth $2,032,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of AVTR. Versant Capital Management Inc grew its stake in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after acquiring an additional 1,102 shares during the period. Blue Trust Inc. raised its stake in Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after buying an additional 1,391 shares during the last quarter. TFO Wealth Partners LLC lifted its holdings in shares of Avantor by 203,100.0% during the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after buying an additional 2,031 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new position in shares of Avantor in the 1st quarter worth $93,000. Finally, ORG Partners LLC grew its holdings in shares of Avantor by 5,773.0% in the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after acquiring an additional 5,773 shares during the period. 95.08% of the stock is owned by institutional investors.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares in the company, valued at approximately $740,372.64. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.50% of the stock is currently owned by corporate insiders.

Avantor Stock Performance

NYSE AVTR opened at $26.87 on Wednesday. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $28.00. The business has a 50-day moving average price of $24.67 and a 200-day moving average price of $24.30. The firm has a market cap of $18.27 billion, a price-to-earnings ratio of 68.90, a price-to-earnings-growth ratio of 2.75 and a beta of 1.32.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. The business had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 5.28% and a return on equity of 12.40%. As a group, equities research analysts predict that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of recent research reports. Barclays increased their target price on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, July 29th. TD Cowen raised their price objective on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Citigroup cut shares of Avantor from a “buy” rating to a “neutral” rating and reduced their target price for the company from $30.00 to $23.00 in a report on Wednesday, July 10th. Robert W. Baird lifted their price target on shares of Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $31.00 price objective on shares of Avantor in a research note on Monday, July 29th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, Avantor presently has an average rating of “Moderate Buy” and an average price target of $27.40.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.